Phase 1, Open Label, Randomized, Single dose, 3 Period, 3 treatment study to evaluation the relative Bioavailability of D-0502 tablet formulation in healthy female subjects
Relative Bioavailability study of D-0502 tablet formulation in healthy female subjects